During the past decade, Clinical Research Partners, LLC conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 31 clinical trials were completed, i.e. on average, 54.4% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 23 clinical trials were completed. i.e. 63.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Partners, LLC" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Incyte Corporation" with 5 trials sponsored, "ModernaTX, Inc." with 5 trials sponsored, "Pfizer" with 5 trials sponsored and "Janssen Research & Development, LLC" with 5 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Partners, LLC" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Covance" with 1 trials as a collaborator and "Institute for the Study of Aging (ISOA)" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Partners, LLC" are "Atopic Dermatitis" (7 trials), "Crohn's Disease" (4 trials), "Asthma" (3 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (3 trials) and "Diabetes Mellitus, Type 2" (3 trials). Many other conditions were trialed in "Clinical Research Partners, LLC" in a lesser frequency.

Most popular intervention types in "Clinical Research Partners, LLC" are "Drug" (58 trials), "Biological" (16 trials), "Other" (13 trials), "Behavioral" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "Mifepristone" (3 trials), "Ruxolitinib cream" (3 trials), "mRNA-1273.214" (3 trials) and "Ad26.COV2.S" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Partners, LLC" are 70 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Research Partners, LLC". undefined are not yet recruiting, 11 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Clinical Research Partners, LLC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Partners, LLC, 4 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 2 trials that are defined as “Not Applicable".